
Michael Eisenstein
Writer and Editor at Freelance
Science writer and editor. Done with this place. Find me on BlueSky, same name.
Articles
-
2 months ago |
nature.com | Michael Eisenstein
In the United States, healthy people are routinely screened for signs of a handful of cancers — women entering middle age should schedule a routine mammogram to check for breast cancer, for example. Unfortunately, this kind of early-detection programme is not the norm for all cancers; most malignancies are spotted only at more advanced stages, when people already have symptoms and treatments are much less effective.
-
2 months ago |
nature.com | Michael Eisenstein
When Patrick Yizhi Cai reflects on the state of synthetic genomics, he recalls the Big DNA Contest. Launched in 2004, the competition challenged synthetic biologists to design a novel, functional 40,000-base-pair DNA sequence that the contest sponsor, US DNA-synthesis firm Blue Heron Biotech (now Eurofins Genomics Blue Heron) would manufacture for free.
-
Jan 20, 2025 |
nature.com | Michael Eisenstein
From sustainable architecture, cancer therapies and bioremediation to photonic computing, here are seven technologies that Nature will be keeping its eye on this year. ‘Self-driving’ laboratoriesLast year, an international team announced a raft of promising materials for use in organic solid-state lasers1.
-
Jan 7, 2025 |
photonics.com | Michael Eisenstein
Uncrewed aircraft can effectively bring sensor systems into challenging environments. Implementing these advanced systems can require a large investment and considerable planning. Mines are inherently challenging places to work, but even within such an environment, certain tasks are considered particularly risky.
-
Nov 24, 2024 |
nature.com | Michael Eisenstein
To people with cancer, tumours can seem like amorphous clumps of defective cells, relentlessly focused on unconstrained growth and invasion. But this does not mean that they’re homogeneous. Cancerous cells have a broad spectrum of mutations, and growths contain healthy host cells, blood vessels and microscale fronts at which immune cells wage war with malignant tissue. Until around a decade ago, researchers were ill-equipped to explore this tumour microenvironment.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 158
- Tweets
- 94
- DMs Open
- Yes